These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28754903)

  • 1. Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy.
    Tsuneyoshi Y; Higuchi A; Negishi K; Tsubota K
    Sci Rep; 2017 Jul; 7(1):6819. PubMed ID: 28754903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of Dissolution Rate and Stability in a Pirenoxine Ophthalmic Suspension by the Bead Mill Methods].
    Ueno A; Yamaoka S; Ito Y; Kotake T; Nakazawa Y; Nagai N
    Yakugaku Zasshi; 2017; 137(5):635-641. PubMed ID: 28458295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy.
    Tsuneyoshi Y; Higuchi A; Negishi K; Tsubota K
    Sci Rep; 2020 Apr; 10(1):6757. PubMed ID: 32296100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are physicians not persuaded by scientific evidence? A grounded theory interview study.
    Sekimoto M; Imanaka Y; Kitano N; Ishizaki T; Takahashi O
    BMC Health Serv Res; 2006 Jul; 6():92. PubMed ID: 16872522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatments for the correction of presbyopia.
    Fernández Jiménez-Ortiz H; Toledano Fernández N
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Aug; 99(8):331-339. PubMed ID: 38663714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of herbal coded formulation ocucure for the improvement of presbyopia: a randomized comparative clinical trial.
    Khan MM; Usmanghani K; Nazar H; Asif HM
    Pak J Pharm Sci; 2014 Mar; 27(2):317-20. PubMed ID: 24577921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of pirenoxine and U74389F on induced lipid peroxidation in mammalian lenses. An in vitro, ex vivo and in vivo study.
    Ciuffi M; Neri S; Franchi-Micheli S; Failli P; Zilletti L; Moncelli MR; Guidelli R
    Exp Eye Res; 1999 Mar; 68(3):347-59. PubMed ID: 10079143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Presbyopic Vision With Miotics.
    Abdelkader A
    Eye Contact Lens; 2015 Sep; 41(5):323-7. PubMed ID: 25806674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments of presbyopia: a review of modern perspectives.
    Renna A; Alió JL; Vejarano LF
    Eye Vis (Lond); 2017; 4():3. PubMed ID: 28191476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.
    Babizhayev MA; Kasus-Jacobi A
    Curr Clin Pharmacol; 2009 Jan; 4(1):4-37. PubMed ID: 19149498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior ciliary sclerotomy for treatment of presbyopia: a prospective controlled study.
    Hamilton DR; Davidorf JM; Maloney RK
    Ophthalmology; 2002 Nov; 109(11):1970-6; discussion 1976-7. PubMed ID: 12414400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral consumption of α-glucosyl-hesperidin could prevent lens hardening, which causes presbyopia.
    Nakazawa Y; Aoki M; Doki Y; Morishita N; Endo S; Nagai N; Funakoshi-Tago M; Tamura H
    Biochem Biophys Rep; 2021 Mar; 25():100885. PubMed ID: 33392397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lens fluorescence and accommodative amplitude in pre-presbyopic and presbyopic subjects.
    Luo X; Kymes SM; Gordon MO; Bassnett S
    Exp Eye Res; 2007 May; 84(5):1013-7. PubMed ID: 17359974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
    Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of two different surgical treatments of presbyopia for hyperopic patients over 55 years old: Presbylasik (Supracor) and Prelex (presbyopic lens exchange)].
    Moyal L; Abrieu-Lacaille M; Bonnel S; Sendon D; de Rivoyre B; Berguiga M; Rambaud C; Froussart-Maille F; Rigal-Sastourné JC
    J Fr Ophtalmol; 2015 Apr; 38(4):306-15. PubMed ID: 25842151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of catalin eyed drops in age-related cataract agents].
    Polunin GS; Makarova IA; Bubnova IA
    Vestn Oftalmol; 2010; 126(1):36-9. PubMed ID: 20645574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective versus objective accommodative amplitude: preschool to presbyopia.
    Anderson HA; Stuebing KK
    Optom Vis Sci; 2014 Nov; 91(11):1290-301. PubMed ID: 25602235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized intraindividual comparison of the accommodative performance of the bag-in-the-lens intraocular lens in presbyopic eyes.
    Cleary G; Spalton DJ; Gala KB
    Am J Ophthalmol; 2010 Nov; 150(5):619-627.e1. PubMed ID: 20719298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presbyopia and velocity of sound in the lens.
    Beers AP; Van der Heijde GL
    Optom Vis Sci; 1994 Apr; 71(4):250-3. PubMed ID: 8047337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of scleral expansion band segments for the treatment of presbyopia.
    Qazi MA; Pepose JS; Shuster JJ
    Am J Ophthalmol; 2002 Dec; 134(6):808-15. PubMed ID: 12470747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.